BELLUS Health (BLU) Stock Price & Analysis


BLU Stock Chart & Stats

Day’s Range$14.74 - $14.75
52-Week Range― - ―
Previous Close$14.74
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding126,684,403
10 Day Avg. Volume4,640,924
30 Day Avg. Volume2,930,237
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)622442.69
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside0.07% Upside
Rating ConsensusHold
Number of Analyst Covering5




What was BELLUS Health’s price range in the past 12 months?
Currently, no data Available
What is BELLUS Health’s market cap?
Currently, no data Available
When is BELLUS Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BELLUS Health’s earnings last quarter?
Currently, no data Available
Is BELLUS Health overvalued?
According to Wall Street analysts BELLUS Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does BELLUS Health pay dividends?
    BELLUS Health does not currently pay dividends.
    What is BELLUS Health’s EPS estimate?
    BELLUS Health’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does BELLUS Health have?
    Currently, no data Available
    What happened to BELLUS Health’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of BELLUS Health?
    Among the largest hedge funds holding BELLUS Health’s share is RA Capital Management. It holds BELLUS Health’s shares valued at 91M.


      BELLUS Health Stock Smart Score

      The BELLUS Health stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      BELLUS Health

      BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      BioLife Solutions
      Corbus Pharmaceuticals
      Crispr Therapeutics AG
      Gritstone Oncology

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis